Generic drugs in oncology - Authors' reply.
Saved in:
| Title: | Generic drugs in oncology - Authors' reply. |
|---|---|
| Authors: | Bennett CL; Hollings Cancer Center of the Medical University of South Carolina, Charleston, SC, USA; University of South Carolina, Columbia, SC, USA. Electronic address: bennettc@sccp.sc.edu., Nagai S; Institute of Medical Science, University of Tokyo, Tokyo, Japan., Yang YT; George Mason University, Fairfax, VA, USA., Chen BK; University of South Carolina, Columbia, SC, USA., Sartor O; Department of Medicine and Tulane University Cancer Center, Tulane University Medical School, New Orleans, LA, USA., Armitage JO; University of Nebraska School of Medicine, Omaha, NE, USA. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2017 Feb; Vol. 18 (2), pp. e64. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
